Planned website maintenance is taking place on Tuesday 5 May 2026, from 6.00 pm to 6.30 pm (AEDT). Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
(Approval lapsed) ATENZA methylphenidate hydrochloride 54mg prolonged-release tablets (Spain)
Section 19A approved medicine
(Approval lapsed) ATENZA methylphenidate hydrochloride 54mg prolonged-release tablets (Spain)
Section 19A approval holder
Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234
Phone
1800 195 055
Approved until
Status
Expired
Medicines in short supply/unavailable
CONCERTA methylphenidate hydrochloride 54mg modified release tablet bottle - ARTG 93864
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle - ARTG 370899
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle - ARTG 370899
Indication(s)
Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Treatment should be commenced by a specialist.
Images
